Thank you for your interest in this story
To continue reading this article, sign up today to unlock exclusive content and be part of our community discussions
- Exclusive discounts
- Enjoy commenting on local issues
Already a subscriber? Log in here.
11
May 2021
Woman died at Harrogate hospital after receiving Oxford-AstraZeneca jab
It has emerged that a woman died at Harrogate District Hospital after receiving the Oxford-AstraZeneca covid vaccine.
Deaths from the vaccine are exceptionally rare but the Financial Times revealed a 59-year-old woman called Julia began having headaches in mid-March, nine days after receiving her first jab.
She initially thought she was suffering migraines but on March 29 her husband, a retired doctor called Peter, came home to find her in a coma.
According to the FT, doctors at the Harrogate hospital said she had a “catastrophic brain injury” resulting from cerebral venous sinus thrombosis and a very low platelet count — the rare blood condition linked to the AstraZeneca jab. Two days later she died.
According to the government, just over 10 people develop adverse drug reactions for every million doses of the Oxford-AstraZeneca vaccine given.
Read more:
- Harrogate district first covid vaccine doses near 100,000
- GP praises vaccine progress but warns against relaxing too soon
A UK Medicines and Healthcare products Regulatory Agency spokesperson said:
A Harrogate and District NHS Foundation Trust spokesman declined to comment.
Three covid vaccines have been authorised for supply in the UK by the MHRA.
Besides Oxford-AstraZeneca, the Pfizer/BioNTech and Moderna vaccines have been approved for use following reviews of safety, quality and efficacy information from clinical trials.
Further information on vaccines is available here.
0